Kimberly Manhard - May 24, 2024 Form 3 Insider Report for Inhibrx Biosciences, Inc. (INXB)

Role
Director
Signature
/s/ Kelly D. Deck, Chief Financial Officer of Inhibrx Biosciences, Inc., as attorney-in-fact
Stock symbol
INXB
Transactions as of
May 24, 2024
Transactions value $
$0
Form type
3
Date filed
5/24/2024, 04:48 PM
Previous filing
May 30, 2023
Next filing
May 30, 2024

No securities are beneficially owned.

Remarks:

Exhibit 24.1 - Power of Attorney